RXRX Recursion Pharmaceuticals In

held by 1 manager in Q3 2021

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.19%	3 mo	NEW	$6M	259,941

Search